Stock Research: Hanmi Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Hanmi Pharmaceutical

KOSE:A128940 KR7128940004
59
  • Value
    10
  • Growth
    96
  • Safety
    Safety
    16
  • Combined
    25
  • Sentiment
    96
  • 360° View
    360° View
    59
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Hanmi Pharm Co Ltd manufactures and sells pharmaceuticals. It operates in the pharmaceuticals and materials processing industries, and exports its products. In the last fiscal year, the company had a market cap of $2,625 million, profits of $553 million, and revenue of $1,013 million. There is no data for the number of employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 59 (better than 59% compared with alternatives), overall professional sentiment and financial characteristics for the stock Hanmi Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Hanmi Pharmaceutical. The consolidated Growth Rank has a good rank of 96, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 96% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 16, which means that the share price of Hanmi Pharmaceutical is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 84% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 10, which means that the company has a financing structure that is riskier than those of 90% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Low Emissions
Energy Efficient
KOSPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 16 14 15
Growth
96 72 91 91
Safety
Safety
10 10 10 1
Sentiment
96 72 96 39
360° View
360° View
59 10 49 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
84 81 67 76
Opinions Change
73 32 75 42
Pro Holdings
n/a 70 74 12
Market Pulse
70 63 72 56
Sentiment
96 72 96 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 16 14 15
Growth
96 72 91 91
Safety Safety
10 10 10 1
Combined
25 1 27 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
32 30 26 14
Price vs. Earnings (P/E)
25 28 30 39
Price vs. Book (P/B)
21 19 12 14
Dividend Yield
26 20 22 17
Value
16 16 14 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
73 61 61 52
Profit Growth
76 56 85 100
Capital Growth
95 90 75 88
Stock Returns
56 28 63 27
Growth
96 72 91 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
27 23 9 2
Refinancing
12 14 9 5
Liquidity
34 75 28 16
Safety Safety
10 10 10 1

Similar Stocks

Discover high‑ranked alternatives to Hanmi Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Kia Motors

KOSE:A000270
Country: South Korea
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Tsumura

TSE:4540
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.